synagis injection age
Synagis is indicated for the prevention of serious lower respiratory tract disease requiring hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk for RSV disease: â¢ Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the RSV season.